Taking into account that RELN promoter regulation depends on various factors (see [40] for details), further studies are needed to determine the specific modulation of RELN promoter in different neurodegenerative diseases (i.e., those affecting neocortical compared to hippocampal regions, or displaying MCI in the presence or absence of AD markers in CSF). This evidence concerns the gene RELN and neurodegenerative disease.